Real-time image processing for label-free enrichment of Actinobacteria cultivated in picolitre droplets†
Abstract
The majority of today's antimicrobial therapeutics is derived from
* Corresponding authors
a
Bio Pilot Plant, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany
E-mail:
martin.roth@hki-jena.de
b
Applied Systems Biology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany
E-mail:
thilo.figge@hki-jena.de
c German Rheumatism Research Centre (DRFZ), Berlin, Germany
d Nanobiophotonics, Institute of Photonic Technology (IPHT), Jena, Germany
e Friedrich Schiller University, Jena, Germany
The majority of today's antimicrobial therapeutics is derived from
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material.
Reproduced material should be attributed as follows:
Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.
Fetching data from CrossRef.
This may take some time to load.